Remdesivir
Showing 26 - 50 of 256
Covid19 Trial in Hong Kong (Interferon beta-1b, Remdesivir)
Recruiting
- Covid19
- Interferon beta-1b
- Remdesivir
-
Hong Kong, Hong KongQueen Mary Hospital
Dec 9, 2020
Covid19, SARS-CoV Infection, Corona Virus Infection Trial in London (SARS-CoV-2 Virus, Remdesivir)
Completed
- Covid19
- +4 more
- SARS-CoV-2 Virus
- Remdesivir
-
London, United Kingdom
- +1 more
Jul 27, 2022
Observational Study in COVID-19 Patients Treated With Remdesivir
Recruiting
- Hospitalization
- no experimental intervention
-
Acqui Terme, (al), Italy
- +29 more
Feb 14, 2022
Treatment of COVID-19 Infection in Nepal : A Registry Study
Recruiting
- Covid19
- Remdesivir
-
Birgunj, Nepal
- +3 more
Dec 15, 2020
Clinical Outcomes in Covid-19 Who Have Been Treated With
Recruiting
- Covid19
- Remdesivir
-
Nantes, France
- +11 more
Apr 14, 2021
SARS-CoV Infection Trial in Lahore (Remdesivir)
Unknown status
- SARS-CoV Infection
- Remdesivir
-
Lahore, Punjab, PakistanMuhammad Irfan Malik
Sep 24, 2020
Covid19, Pneumonia Trial in Bani Suwayf (Remdesivir, Hydroxychloroquine, Tocilizumab)
Recruiting
- Covid19
- Pneumonia
- Remdesivir
- +4 more
-
Banī Suwayf, EgyptBeni-suef University
Mar 15, 2021
Covid19 Trial in Kingston (Remdesivir, Acalabrutinib, Interferon beta-1a)
Not yet recruiting
- Covid19
- Remdesivir
- +3 more
-
Kingston, JamaicaUniveristy of the West Indies
May 10, 2021
Covid19 Trial in Italy (Baricitinib Oral Tablet [Olumiant], Remdesivir, Dexamethasone)
Not yet recruiting
- Covid19
- Baricitinib Oral Tablet [Olumiant]
- +2 more
-
Ancona, Italy
- +20 more
Apr 3, 2021
COVID-19 Trial in Worldwide (Remdesivir, RDV Placebo, Standard of Care)
Terminated
- COVID-19
- Remdesivir
- +2 more
-
Birmingham, Alabama
- +62 more
Jun 1, 2022
Covid19, Covid-19 ARDS Trial in Dinajpur (Remdesivir, Baricitinib, Tocilizumab)
Recruiting
- Covid19
- Covid-19 ARDS
- Remdesivir
- +2 more
-
Dinajpur, BangladeshM. Abdur Rahim Medical College Hospital
Dec 31, 2020
Convalescent Plasma and Remdesivir Therapy in Nepal
Unknown status
- COVID-19
- Convalescent Plasma
-
Birgunj, Nepal
- +5 more
Sep 29, 2020
COVID-19, Remdesivir, SARS-CoV-2 Trial in Beijing (Remdesivir, Remdesivir )
Terminated
- COVID-19
- +2 more
- Remdesivir
- Remdesivir placebo
-
Beijing, Beijing, ChinaBin Cao
Apr 13, 2020
COVID-19, SARS-CoV-2 Trial in Wuhan (Remdesivir, Remdesivir )
Suspended
- COVID-19
- SARS-CoV-2
- Remdesivir
- Remdesivir placebo
-
Wuhan, Hubei, ChinaJin Yin-tan hospital
Apr 13, 2020
Corona Virus Disease 2019 (COVID-19) Trial in Lahore (Tocilizumab)
Completed
- Corona Virus Disease 2019 (COVID-19)
-
Lahore, Punjab, PakistanThe University of Lahore
Dec 30, 2020